Novartis AG
Stock Forecast, Prediction & Price Target
Novartis AG (NVS) stock Price Target by analysts
$120
Potential downside: -4.45%
Novartis AG price prediction
What is Novartis AG stock analysts` prediction?
Novartis AG stock forecast: Based on 1 Wall Street analysts` predicted price targets for Novartis AG in the last 3 months, the avarage price target is $120, with a high forecast of $NaN. The average price target represents a -4.45% change from the last price of $125.6.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Novartis AG stock Price Target by analysts
Full breakdown of analysts given Novartis AG price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Etzer Darout BMO Capital | 0% 0/2 | 11 months ago | $120 -4.45% downside | $109.91 | StreetInsider | Previous targets (1) |
James Quigley Goldman Sachs | 0% 0/1 | about 1 year ago | $121 -3.66% downside | $119.38 | TheFly | Previous targets (0) |
Etzer Darout BMO Capital | 0% 0/2 | about 1 year ago | $118 -6.05% downside | $106.13 | StreetInsider | Previous targets (1) |
Wan Nurhayati CFRA | 0% 0/1 | over 1 year ago | $108 -14.01% downside | $97.27 | StreetInsider | Previous targets (0) |
Novartis AG Financial Estimates
Novartis AG Revenue Estimates
Novartis AG EBITDA Estimates
Novartis AG Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $52.87B N/A | $51.82B -1.98% | $46.66B -9.97% | Avg: $51.47B Low: $49.68B High: $53.15B avg. 10.30% | Avg: $52.24B Low: $50.21B High: $53.92B avg. 1.51% | Avg: $52.49B Low: $50.44B High: $54.17B avg. 0.46% | Avg: $53.32B Low: $51.25B High: $55.03B avg. 1.59% |
Net Income
% change YoY
| $24.02B N/A | $6.95B -71.04% | $14.85B 113.51% | Avg: $16.65B Low: $15.47B High: $17.51B avg. 12.16% | Avg: $17.38B Low: $16.50B High: $18.11B avg. 4.37% | Avg: $17.82B Low: $16.92B High: $18.56B avg. 2.53% | Avg: $18.84B Low: $17.89B High: $19.63B avg. 5.71% |
EBITDA
% change YoY
| $33.06B N/A | $16.38B -50.42% | $18.28B 11.57% | Avg: $20.61B Low: $19.90B High: $21.29B avg. 12.75% | Avg: $20.93B Low: $20.11B High: $21.60B avg. 1.51% | Avg: $21.02B Low: $20.20B High: $21.70B avg. 0.46% | Avg: $21.36B Low: $20.53B High: $22.04B avg. 1.59% |
EPS
% change YoY
| $10.71 N/A | $3.19 -70.21% | $7.15 124.13% | Avg: $7.96 Low: $7.4 High: $8.37 avg. 11.36% | Avg: $8.31 Low: $7.89 High: $8.66 avg. 4.37% | Avg: $8.52 Low: $8.09 High: $8.88 avg. 2.53% | Avg: $9.01 Low: $8.55 High: $9.38 avg. 5.71% |
Operating Expenses
% change YoY
| $25.32B N/A | $27.14B 7.20% | $24.41B -10.04% | Avg: $14.45B Low: $13.95B High: $14.93B avg. -40.79% | Avg: $14.67B Low: $14.10B High: $15.14B avg. 1.51% | Avg: $14.74B Low: $14.17B High: $15.21B avg. 0.46% | Avg: $14.97B Low: $14.39B High: $15.46B avg. 1.59% |
FAQ
What is Novartis AG stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 6.19% in 2025-2028.
We have gathered data from 12 analysts. Their low estimate is 15.47B, average is 16.65B and high is 17.51B.
What is Novartis AG stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 3.46% in 2025-2028.
We have gathered data from 11 analysts. Their low revenue estimate is $49.68B, average is $51.47B and high is $53.15B.
What is Novartis AG stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 5.99% in 2025-2028.
We have gathered data from 12 analysts. Their low earnings per share estimate is $7.4, average is $7.96 and high is $8.37.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Novartis AG stock. The most successful analyst is Etzer Darout.